Health experts tell Ottawa to hurry domestic vaccine funding amid China delays

The federal government has created a $600-million fund to support vaccine clinical trials

The Trudeau government is being pressed to approve funding for a made-in-Canada COVID-19 vaccine to lessen the risk Canadians will have to line up and wait on a foreign-made pandemic cure.

For instance, health-care professionals have written to Innovation Minister Navdeep Bains to urge him make up his mind on a proposal submitted in April by Providence Therapeutics of Toronto. The company is seeking $35 million to establish whether its vaccine is effective in humans after successful animal trials.

They say Canada has no guarantee it will be at the front of any line for an internationally produced pandemic cure. They attribute government’s slowness to a long-standing public policy problem: reluctance to partner with pharmaceutical and biotech companies in the same way it has tried to bolster other sectors.

“When you’re dealing with a pandemic like this and the government has already spent millions of dollars on all sorts of things, an additional investment into another vaccine technology, to increase our shots on goal in Canada, to help ensure that we actually develop the best vaccine, the most efficacious vaccine, I think to me makes sense,” said Laszlo Radvanyi, the president and scientific director of the publicly funded Ontario Institute for Cancer Research.

ALSO READ: Should a vaccine for COVID-19 be made mandatory in Canada, once it’s created?

The federal government has created a $600-million fund to support vaccine clinical trials and manufacturing inside Canada.

Providence has told the government it could deliver five million doses of its new mRNA vaccine by mid-2021 for use in Canada if it were able to successfully complete human testing.

The mRNA technology is new and untested but experts say it has potential.

Radvanyi and others say the research deserves support because there are troubling signs Canadians might have wait to receive a vaccine that is invented abroad.

Canada has already invested in a vaccine-development partnership between China’s CanSino Biologics and Dalhousie University in Nova Scotia but China has held up shipments it was supposed to send to Dalhousie researchers by the end of May to start human trials.

Canada-China relations are severely strained after the People’s Republic imprisoned two Canadian men, Michael Kovrig and Michael Spavor, in apparent retaliation for the RCMP’s arresting Chinese high-tech executive Meng Wanzhou on an American extradition warrant in December 2018.

“This should have been flagged as an obstacle when contemplating doing this program. We’re not on the best of terms with the Chinese government,” said Radvanyi, who has collaborated with Providence on vaccine treatments for cancer and wrote to Bains to support the company.

He also stressed that his support is based purely on the merits of the science behind the proposal.

“With any new technology, one needs to be careful not to drink the Kool-Aid and let the data and the science speak for itself. But clearly there are really promising data emerging” from new mRNA vaccine tests, including from the American company Moderna Inc. and the German firm BioNTech SE, said Radvanyi.

Both those companies have been heavily funded through U.S. President Donald Trump’s “Operation Warp Speed” program to fast-track a vaccine for the novel coronavirus.

This week the U.S. committed to pay BioNTech and its American partner Pfizer $1.95 billion to produce 100 million doses if their vaccine candidate proves safe and effective in humans. In April, the U.S. agreed to pay Moderna up to $483 million to fund its research. Next week, Moderna is set to launch a 30,000-person final round of testing to test the strength of its vaccine candidate.

“The mRNA technology is a newer more experimental technology but completely worthy of being part of the actual analysis which is being undertaken and will be considered as part of the investment portfolio,” Canada’s chief public health officer Dr. Theresa Tam said Friday.

Tam said the government is carefully examining data, while trying to take an “accelerated approach not just on the regulatory and clinical trial front, but also an accelerated approach on looking at investments as well.”

Providence’s chief executive Brad Sorenson said he has heard “crickets” from Ottawa since late May after his company submitted its proposal in April — after the government reached out to it as a possible vaccine-maker.

“We need a Canadian solution, a manufacturing solution in Canada. All of our (intellectual property), all of our manufacturing, all of the work we are doing is inside Canada,” said Sorenson.

The company wants to move forward with human trials because it has generated neutralizing antibodies in animals, with the same technology that BioNTech and Moderna have used, said Sorenson.

“We had identified space to do a manufacturing run for our vaccine in September. We’ve lost that space now because we didn’t get any support, and we couldn’t hold it indefinitely.

“The next opportunity for us to manufacture would be late October, early November. So literally, we’re ready to do it. We just need the co-operation.”

Health Minister Patty Hajdu said vaccine applications are not “sitting around, gathering dust” and the government’s vaccine task force of experts was carefully reviewing them.

Bains spokesman John Power said he couldn’t comment on specific proposals, but said the evaluation process is ongoing.

Brad Wouters, executive vice-president of science and research at Toronto’s University Health Network, said the time has come for Canada to “hedge” its bets and support Providence, given the hold-up of the Chinese shipment.

“This, to me, is sort of a no-brainer to give these guys a shot, especially with the promising data coming out of the U.S. and other places,” said Wouters, who also wrote to Bains to support Providence.

The new mRNA technology is a departure from how vaccines have traditionally been made to counter the flu or polio, for example. The traditional approach involves taking some of the actual virus, rendering it safe or inactive and then injecting it into the human body to create an immune response.

Instead, the mRNA approach involves injecting a key fragment of genetic material from the virus so the human body can produce the viral proteins needed to mount an immune response, said Wouters.

One advantage of mRNA vaccines is they’re relatively inexpensive to produce, said Tania Watts, a professor of immunology at the University of Toronto, who is conducting a study on how long immunity to COVID-19 lasts in people who have recovered from infections.

“They’re chemically made so you don’t need to have live virus and you don’t have to grow cells. The first trials from Moderna look like two doses gave really great antibody responses,” she said.

But Watts said more research is needed to establish how effective the new vaccines are.

Watts she said she doesn’t necessarily favour Providence or any other project that has succeeded in getting federal funding, but said it has one among many “promising platforms” for a vaccine.

Watts said the government should back a made-in-Canada vaccine because China, and even the U.S., can’t be relied upon to share one. She also said that multiple vaccines in multiple doses is the likely end-game scenario for the pandemic.

“We don’t know if vaccines made outside Canada are going to be available to us,” said Watts. “If you were the U.S., you’d probably want to make sure that your own supply was secured first.”

Radvanyi said the COVID-19 vaccine race has exposed the government’s flawed approach in collaborating with a private sector driven by profit motives.

“There has to be a motive to make money to sustain operations, but through a public-private partnership the government can help drive a new paradigm in terms of drug development and manufacturing.”

Mike Blanchfield, The Canadian Press

Like us on Facebook and follow us on Twitter.

Want to support local journalism? Make a donation here.

Coronavirus

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

robbery
Rimbey RCMP investigating shooting

Police responded to a complaint of an armed robbery at the Bluffton City General Store

The influenza vaccine will be available at no cost starting Monday in Alberta. “The more that we can avoid influenza-related tests, emergency visits and hospitalizations, the stronger our system will be to support those with COVID-19 and all other health needs," says Dr. Deena Hinshaw, the province's chief medical officer of health. (AP Photo/Ted S. Warren)
Hinshaw urges Albertans to get flu shot as COVID cases jump by 332

Alberta’s central zone now has 132 active COVID-19 cases

The Bellows family on vacation last year in Mexico. L-R: Angel, Ryan, Darrel, Grace and Michael. (Photo submitted)
Rimbey community rallying behind family after cancer diagnosis

Michael Bellows, 12, a ‘strong, resilient kid’ says father

Across the province, there are 2,738 active cases of COVID-19, with 18,417 recovered cases. There have been 288 deaths from the virus in Alberta since the beginning of the pandemic. (File photo)
Alberta reports 244 additional COVID-19 cases Thursday

2,738 active cases of COVID-19 in the province

(File Photo)
Batten down the hatches, a dump of snow expected Friday afternoon

Environment Canada issued a special weather statement as upwards of 10 cm of snow is expected

In this photo provided by Shannon Kiss, smoke from the CalWood Fire billows, Sunday, Oct. 18, 2020, as seen from Gunbarrel, Colo. (Shannon Kiss via AP)
‘First guys out:’ western Canadian air tanker fleet busy despite drop in wildfires

CEO believes wildfires have become more dangerous in recent years as people live closer to where they start

Canadian and American flags fly near the Ambassador Bridge at the Canada-USA border crossing in Windsor, Ont. on Saturday, March 21, 2020. Restrictions on non-essential travel between Canada and the United States are being extended until at least Nov. 21. THE CANADIAN PRESS/Rob Gurdebeke
Non-essential travel restrictions at Canada-U.S. border extended to at least Nov. 21

The restrictions do not apply to those providing essential services in either country

(The Canadian Perss)
Banff wolves have lower survival rate due to hunting, trapping outside park boundary

Researchers looked at 72 radio-collared wolves in the national park from 1987 to August 2019

Democratic presidential candidate and former Vice President Joe Biden speaks at Miramar Regional Park in Miramar, Fla., Tuesday, Oct. 13, 2020. Alberta Premier Jason Kenney is still hopeful about the Keystone pipeline if there’s a change in government in the U.S. next month, saying Alberta has been engaging with American officials from both sides of the aisle. THE CANADIAN PRESS/AP-Carolyn Kaster
Alberta premier says he’s still hopeful about Keystone, even if Biden elected

The Alberta government has agreed to invest about US$1.1 billion as equity in the project

Chief Public Health Officer Dr. Theresa Tam takes part during a press conference during the COVID pandemic in Ottawa on Friday, Oct. 16, 2020. As parts of Canada face a new round of COVID-19-related restrictions, Canada’s chief public health officer is urging Canadians to continue making a “collective effort” to tackle the pandemic.THE CANADIAN PRESS/Sean Kilpatrick
Chief public health officer calls for continued ‘collective effort’ against COVID-19

Canada continues to climb toward the 200,000 mark for COVID-19 cases

Employee Sophia Lovink shows off a bag of merchandise in Toronto on Thursday, June 11, 2020. (THE CANADIAN PRESS/Nathan Denette)
Canada gets C-average grade on 2nd year of cannabis legalization

Cannabis Council of Canada releases report card on federal government and legalization

This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, yellow, emerging from the surface of cells, blue/pink, cultured in the lab. Also known as 2019-nCoV, the virus causes COVID-19. THE CANADIAN PRESS/AP, NIAID-RML
Officer with Prince Albert Police tests positive for COVID-19, force says

Police co-operating with the provincial health authority’s efforts to trace the officer’s contacts

Smoke haze from forest fires burning in Alberta and British Columbia hangs over Banff, Alta., in Banff National Park, Friday, July 21, 2017. Visitors to Banff National Park in Alberta will soon have to reserve a spot for a shuttle bus to Lake Louise and Moraine Lake. THE CANADIAN PRESS/Jeff McIntosh
Banff wolves have lower survival rate due to hunting, trapping outside park boundary

Study shows grey wolves in Banff National Park don’t live much longer than those elsewhere in Alberta

Black Press file photo
Fire destroys lobster pound in Nova Scotia, police say man in hospital with injuries

RCMP say a man is in hospital with life threatening injuries

Most Read